MarketInOut Stock Screener Log In | Sign Up
 

Whitehawk Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Whitehawk Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization182.43 mln
Float31.17 mln
Earnings Date11/11/2026

Piotroski F-Score

3 / 9
Below average

1-Year Forecast

7.71
Transformational upside

Relative Strength

27 / 100
Underperforming

ROE

-52.20
Deeply negative

ROA

-48.68
Deeply negative

Business Description

Whitehawk Therapeutics Inc. is a clinical-stage company focused on developing cancer treatments through a portfolio of three advanced antibody drug conjugates. Founded in 2007 and headquartered in Morristown, New Jersey, the company works to better understand how tumors behave in order to improve patient outcomes. Previously operating under the name Aadi Bioscience Inc., the company rebranded to Whitehawk Therapeutics Inc. in August 2021.

Key Fundamentals

EPS-1.14
ROE-52.20
ROIC-1,972
ROA-48.68
EBITDA, mln-79.82
EV / EBITDA-1.79
EV / EBIT-1.79
Revenue, mln7.14
EV / Revenue20.00

Quote Details

Last 3.21
Change -0.04 (-1.23%)
Open 3.23
Volume 222,609
Turnover 714,575
Average Volume 325,327

Financial Ratios

Leverage Ratio1.06
Current Ratio17.38
Price / Book1.17
Price / Tangible Book1.17
Price / Sales32.68

Financial Strength

Piotroski F-Score 3 / 9
1-Year Target Price7.71
Short Ratio7.89
Short % of Float7.67

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 11.07% 95 / 100   
1 Month -16.84% 21 / 100   
2 Months -15.3% 26 / 100   
6 Months -20.35% 26 / 100   
1 Year 35.44% 88 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog